Acta Scientific Medical Sciences (ASMS)(ISSN: 2582-0931)

Letter to Editor Volume 4 Issue 12

Analysis of Consistency of Prime-boost Covid-19 Baseline and Safety Data

Dragutin Novosel1* and Matija Alanović2

1Glaserbergstrasse 23, CH-4056 Basel, Switzerland
2SIPA Elektronika d.o.o., Ruđera Boškovića 17, 47000 Karlovac, Croatia

*Corresponding Author: Dragutin Novosel, Glaserbergstrasse 23, 4056 Basel, Switzerland. E-mail: d.novosel@bluewin.ch

Received: October 23, 2020; Published: November 25, 2020

×

  Recently, some concerns [1-3] have been raised about the reliability of data presented in the current paper [4], which reported results from a non-randomised phase 1/2 study of a novel vaccine from Russia. The critics of the study [4] concentrated on potential data inconsistencies [1-3] in figures and analyzed them visually (here we ignore theoretical discussions about special features of the vaccine and/or vector). However, the baseline data and results of the safety data should be considered as well.

×

Citation

Citation: Dragutin Novosela and Matija Alanovic. “Analysis of Consistency of Prime-boost Covid-19 Baseline and Safety Data". Acta Scientific Medical Sciences 4.12 (2020): 81-82.




Metrics

Acceptance rate30%
Acceptance to publication20-30 days
Impact Factor0.851

Indexed In





News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is September 30, 2021.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US